5 h. ago Excelsoft Technologies Shares Debut At Nearly 13% Premium Over IPO Price

Excelsoft Technologies listed on the BSE at Rs 135.

Economics

18 h. ago Sudeep Pharma IPO Final Subscription Over 93 Times; GMP Falls Ahead Of Listing

Sudeep Pharma IPO: The allotment of shares to IPO investors will be done tentatively on Nov. 26.

Politics

28 h. ago Sudeep Pharma IPO Day Three: Check Subscription Status, Latest GMP

Sudeep Pharma's latest grey market premium has declined to Rs 83 apiece, from Rs 121 earlier, as per Investorgain.

Politics

31 h. ago Excelsoft Technologies IPO Listing: Check Date And GMP Ahead Of D

Excelsoft Technologies Expected Listing Price: Based on the current GMP, investors can expect the stock to debut at a premium of around 5%.

Politics

44 h. ago Sudeep Pharma IPO Day Two Subscription At 500%; GMP Falls Sharply

Sudeep Pharma will list on the BSE and NSE on Nov. 28.

Politics

54 h. ago IPO GMP: Sudeep Pharma Vs Excelsoft Technologies – What Does Grey Market Trends Suggest Ahead Of Listing

Grey market trends offer an early glimpse of investor sentiment and hint at likely performance when the shares list.

Economics

4 d. ago Excelsoft Technologies IPO Day Three: Final Subscription Over 43 Times; GMP Falls

The latest grey market premium of Excelsoft Technolgoies fell to Rs 8 from Rs 14.

Politics

5 d. ago Excelsoft Technologies IPO Falls On Final Day Of Subscription; Track Latest Market Trends

The grey market premium for the Excelsoft Technologies IPO has declined by 65% since November 15, when the GMP was Rs 30.

Economics

5 d. ago IPO GMP Today: Excelsoft Technologies Vs Sudeep Pharma – Latest Grey Market Trends Suggest Up To 20% Gains

The initial grey market trends suggest a positive listing gain of around 12-20% for the mainboard offers of Excelsoft Technologies and Sudeep Pharma.

Economics

5 d. ago Excelsoft Technologies IPO Day Three: Check Subscription Status, Latest GMP

The Excelsoft Technologies IPO has been subscribed 8.8 times as of 10:12 p.m. on Friday.

Politics

5 d. ago Sudeep Pharma IPO Day One: Check Subscription Status, Financials, And Other Details

Sudeep Pharma IPO has been subscribed 0.03 times or 3% as of 10:09 a.m. on Friday.

Economics

5 d. ago Sudeep Pharma IPO Opens With A Healthy GMP; Check Market Trends On Day 1 Of Subscription

The GMP for the Sudeep Pharma IPO has gained by 31% in the last couple of days ahead of its Friday launch.

Economics

6 d. ago Excelsoft Technologies IPO Day Two: Check Subscription Status, GMP, Financials, And Other Details

The Excelsoft Technologies IPO has been subscribed 2.09 times as of 10:25 a.m. on Thursday.

Economics

6 d. ago Excelsoft Technologies IPO GMP In Spotlight On Day 2 Of Subscription; Check Key Details

The grey market premium for the Excelsoft Technologies IPO has declined by 50% since November 15, when the GMP was Rs 30.

Politics

6 d. ago Excelsoft Technologies IPO Fully Subscribed On Day One: Check Latest GMP

The Excelsoft Technologies IPO has been subscribed 1.45 times as of 5:00 p.m. on Wednesday.

Politics

7 d. ago Excelsoft Technologies IPO Subscription Opens On Wednesday: Price Band To GMP

The Excelsoft IPO offer consists of a fresh issue of up to Rs 180 crore and an offer for sale of 2.66 crore shares worth up to Rs 320 crore.

Economics

1 week ago IPO Tracker: Two Issues Open For Bidding This Week; PhysicsWallah Listing In Focus

IPO Tracker: Excelsoft Technologies IPO and one SME issue will open for subscription this week.

Politics

1 week ago Fujiyama Power Systems (UTL Solar) IPO GMP In Focus On Day 2 Of Subscription; Check Details

UTL Solar IPO: The price band for the mainboard IPO has been set at Rs 216-Rs 228 per share.

Politics

1 week ago Capillary Technologies IPO GMP In Focus On Day 1 Of Subscription; Check Key IPO Details

The Capillary Technologies IPO is a book-building issue worth Rs 877.5 crore.

Science

1 week ago PhysicsWallah IPO Subscribed 13% On Day Two; GMP Sees Marginal Uptick

Delhi-based leading ed-tech company PhysicsWallah aims to raise up to Rs 3,100 crore through a fresh issue.

Politics